SLFN11 and ovarian carcinoma: Expression of SLFN11 has been associated with improved response to DNA-damaging agents in ovarian cancer and small cell lung cancer, and enhancing expression of SLFN11 is a potential strategy under investigation to sensitise tumours to PARPi and other DNA-damaging agents [37].